Hamed Soleimani Samarkhazan
17 ta ish
Shahid Beheshti University of Medical Sciences
Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Sharh maqolaOchiq kirish20256 iqtibosABIMacrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, Sina Nouri +5
Sharh maqolaOchiq kirish20255 iqtibosABIRole of Precision Medicine and Personalized Medicine in the Treatment of Diseases
Mehrdad Farrokhi, Fatemeh Taheri, Parisa Jafari Khouzani +25
KitobOchiq kirish20234 iqtibosABINanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
Ashok Kumar Bishoyi, Sina Nouri, Ahmed Hussen +3
Sharh maqolaOchiq kirish20253 iqtibosABIVon Willebrand disease (VWD) and pregnancy: a comprehensive overview
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Ali Rahmati +3
Sharh maqolaOchiq kirish20252 iqtibosABI“Galectin-9: A double-edged sword in Acute Myeloid Leukemia”
Omolbanin Sargazi-Aval, Ali Ahmadi, Ali Jihad Hemid Al-Athari +5
Sharh maqolaOchiq kirish20252 iqtibosABIInsights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies
Sara Zehtabcheh, Hamed Soleimani Samarkhazan, Marjan Asadi +3
Sharh maqolaOchiq kirish20252 iqtibosABIThe microbiome in graft-versus-host disease: a tale of two ecosystems
Hamed Soleimani Samarkhazan, Sina Nouri, Mohsen Maleknia +1
Sharh maqola20252 iqtibosABI